Public Meeting on Patient-Focused Drug Development for Long COVID - 04/25/2023

[FDA]

On April 25th, 2023, FDA is hosting a virtual public meeting on Patient-Focused Drug Development for Long COVID. This meeting will provide FDA the opportunity to obtain initial patient and patient representative input on the aspects of Long COVID, including how Long COVID affects their daily life


Baca selengkapnya di : http://www.fda.gov...